Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.

scientific article published on 22 May 2009

Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJCA.2009.04.037
P698PubMed publication ID19477116

P50authorKlaas Pieter KoopmansQ53136384
Elisabeth de VriesQ64712784
Adrienne H BrouwersQ89035839
P2093author name stringHelle-Brit Fiebrich
P433issue13
P407language of work or nameEnglishQ1860
P921main subjectpositron emission tomographyQ208376
carcinoid tumorQ1734755
P304page(s)2312-2315
P577publication date2009-05-22
P1433published inEuropean Journal of CancerQ332260
P1476titleCombining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients
P478volume45

Reverse relations

Q3808241718F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their typecites workP2860